Detalhe da pesquisa
1.
SMARCB1 regulates the hypoxic stress response in sickle cell trait.
Proc Natl Acad Sci U S A
; 120(21): e2209639120, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186844
2.
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.
Gastroenterology
; 161(1): 196-210, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745946
3.
Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.
Oncogene
; 40(26): 4425-4439, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108622
4.
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer.
JCI Insight
; 6(17)2021 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309585
5.
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways.
Cancers (Basel)
; 13(15)2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359705
6.
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Nat Commun
; 12(1): 4626, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330913
7.
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer.
Cancers (Basel)
; 11(4)2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986992
8.
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism.
Sci Transl Med
; 11(483)2019 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867319
9.
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer.
Nat Commun
; 10(1): 5125, 2019 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719531
10.
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Cell Metab
; 27(5): 977-987.e4, 2018 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628419